According to MHRA product information, constipation is very common (affecting more than 1 in 10 people) with higher doses used for weight management (Wegovy, Saxenda), while it is common (affecting up to 1 in 10 people) with doses typically used for diabetes (Ozempic, Victoza)
Oral tirzepatide treatment has shown great promise in controlling blood sugar and helping with weight loss
Hausner, H., Derving Karsbl, J., Holst, A.G., Jacobsen, J.B., Wagner, F.D., Golor, G., Anderson, T.W
Liver fat In Phase 2a research, hepatic fat fell by roughly 80%+ at 24 weeks
Although GIP and its experimental analogs seem to have a glucagon-elevating effect, its end-action on metabolic parameters, especially when GLP-1 is present, is neutral or tilted towards benefit